New injection aims to tame autoimmune attacks
Disease control
Recruiting now
This early-stage study tests a new injection called AFN50 in 18 adults with active lupus despite standard treatment. The goal is to see if it is safe and can help control the disease by targeting immune cells. Participants will be monitored for side effects and changes in their c…
Phase: EARLY_PHASE1 • Sponsor: AlphaNa Bioscience Company Limited • Aim: Disease control
Last updated May 11, 2026 20:38 UTC